NASDAQ: APYXApyx Medical Corp Stock Ownership - Who owns Apyx Medical?
Insider buying vs selling
Have Apyx Medical Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Matthew C. Hill | Chief Financial Officer | 2024-08-13 | 5,336 | $1.13 | $6.03kBuy |
| Matthew C. Hill | Chief Financial Officer | 2024-08-13 | 6,000 | $1.13 | $6.78kBuy |
APYX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when APYX insiders and whales buy or sell their stock.
APYX Shareholders
What type of owners hold Apyx Medical Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Archon Capital Management LLC | 8.72% | 3,296,744 | $6.30M | Institution |
| Nantahala Capital Management LLC | 8.62% | 3,258,048 | $6.22M | Institution |
| Scott Richard Davidson | 7.09% | 2,680,000 | $5.12M | Insider |
| Royce Associates LP | 6.68% | 2,525,467 | $4.82M | Institution |
| Stavros G. Vizirgianakis | 4.62% | 1,746,191 | $3.34M | Insider |
| Vanguard Group Inc | 3.90% | 1,475,772 | $2.82M | Institution |
| Universal Growth Investment Trust Renn | 3.30% | 1,247,800 | $2.38M | Insider |
| Silverberg Bernstein Capital Management LLC | 1.71% | 646,569 | $1.23M | Institution |
| Andrew Makrides | 1.65% | 624,389 | $1.19M | Insider |
| Horizon Kinetics Asset Management LLC | 1.63% | 615,000 | $1.17M | Institution |
APYX vs Medical Device Stocks
Apyx Medical Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.